Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

NCT07389200 is registered in ClinicalTrials.gov with Hao Xu as lead sponsor.

NCT NCT07389200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07389200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer
Lead sponsor
Hao Xu
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2028
Completion date
December 30, 2029
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer with low to intermediate her2 expression